Erythromycin ethyl succinate

CAS: 1264-62-6

Ref. 3D-FE170906

Información del producto

• Nombre: Erythromycin ethyl succinate
• Sinónimos: (2R,3S,4R,6S)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name), (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione, 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name), 4-Ethoxy-4-Oxo-Butanoate, Anamycin, Arpimycin, Durapaediat, E-Mycin e, Eritrocina, EryPed, Eryliquid, Erythro ES, Erythro-Holz, Erythrocin ethyl succinate, Erythromycin Ethly Succinate., Erythromycin Ethyl Succinate, Erythromycin Ethylsuccinate, Erythromycin, 2′-(ethyl butanedioate), Erythromycin, 2′-(ethyl succinate), Erythromycin, mono(ethyl succinate) (ester), Erythroped, Esinol, Evesin, Monomycin, Oxacyclotetradecane, erythromycin deriv., Paediathrocin, Pediamycin, Refkas, Sigapedil, Succinic acid, ethyl ester, monoester with erythromycin, Wyamycin E

Descripción

Erythromycin ethyl succinate is an ester prodrug that is formed by the reaction of erythromycin and ethylsuccinic acid. It has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. Erythromycin ethyl succinate is also active against Haemophilus influenzae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, Helicobacter pylori, Leptospira interrogans, Bordetella pertussis, Rickettsia rickettsii, Borrelia burgdorferi, Coxiella burnetii, and Mycoplasma pneumoniae. Erythromycin ethyl succinate has been shown to be effective in treating streptococcal pharyngitis and tissue infections.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 862.05 g/mol
• Fórmula: C₄₃H₇₅NO₁₆
• Pureza: Min. 95%